IFN-γ/STAT1 Luciferase Reporter Lentivirus

The IFN-γ/STAT1 luciferase reporter lentivirus is an integrating, pathway-specific sensing tool designed to translate the classic interferon-gamma signaling pathway into a quantitative luminescent signal output. The core of this construct places a luciferase reporter gene under the control of a minimal promoter fused to a tandem interferon-gamma activated sequence (GAS) element recognized by activated STAT1 homodimers. This structure minimizes basal transcription while providing a robust inducible response, resulting in a high signal-to-noise ratio ideal for precise pathway readout. Because the system is a lentiviral vector, it supports stable genomic integration and long-term signal fidelity across cell divisions, enabling the creation of stable reporter cell lines for long-term studies. The readout leverages the inherent broad dynamic range and excellent sensitivity of luciferase, allowing for the detection of subtle changes in STAT1 activity with good reproducibility.

In terms of applications, the IFN-γ/STAT1 luciferase reporter lentivirus is a versatile tool for dissecting immune signaling, characterizing pathway modulators, and quantifying cellular responsiveness to interferon-gamma. It is ideally suited for small molecule and biologic screening to identify agonists, antagonists, or modulators of the JAK/STAT axis, enabling rapid screening of candidate compounds based on pathway potency and efficacy. In immunology and oncology research, this reporter facilitates the exploration of tumor-immune interactions, immune evasion mechanisms, and the impact of cytokine gradients on cellular state, while also supporting studies of checkpoint pathway crosstalk and interferon-driven transcriptional programs. The functional consequences of genetic perturbation studies (e.g., CRISPR, RNAi, or expression of pathway variants) can be assessed by measuring changes in luciferase output, allowing researchers to map upstream or downstream regulators of STAT1, evaluate gain-of-function or loss-of-function alleles, and uncover compensatory signaling pathways.